Longitudinal MRI Tumor Segmentation for Radiotherapy Outcomes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for assessing radiotherapy outcome in brain tumors rely heavily on manual segmentation of MRI scans, which is tedious and time-consuming, and existing deep learning models struggle with memory limitations and inefficient handling of spatial dependencies, leading to suboptimal performance in differentiating between tumor progression and adverse radiation effects.
Innovation Solution
A machine-learning-based segmentation framework using a cascade of 2D and 3D UNets, combined with a multi-scale attention-guided network, to automatically delineate tumors on serial MRI scans, overcoming memory constraints and improving precision in tumor size assessment and differentiation between tumor progression and adverse radiation effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If manual segmentation of MRI scans is used to assess radiotherapy outcome, then expert clinical judgment can be applied, but the process becomes tedious and time-consuming
Solution Approach 1:
The patent replaces the manual mechanical segmentation process performed by experts with an automated deep learning system. The system uses trained neural networks to automatically delineate tumors on serial MRI scans, eliminating the need for manual tracing while maintaining high accuracy. This substitution directly resolves the contradiction by providing both precise measurement and time efficiency.
Solution Approach 2:
The system enables self-service automation where the segmentation framework performs tumor delineation autonomously without requiring continuous expert intervention. The automated framework processes MRI scans, calculates tumor dimensions, and assesses radiotherapy outcomes independently, significantly reducing the time investment required while preserving measurement precision.
2Extent of automation
If existing deep learning models are used for tumor segmentation, then automation is achieved, but memory limitations and inefficient spatial dependency handling reduce performance
Solution Approach 1:
The patent divides the automated segmentation task into distinct modular components: a first deep learning model handles initial tumor region identification, while a second deep learning model performs refined segmentation and differentiation between tumor progression and adverse radiation effects. This segmentation of the automation process improves reliability by allowing each model to specialize in specific aspects of the challenging differentiation task.
Solution Approach 2:
The system introduces an intermediary mechanism that processes spatial dependencies and contextual information between serial MRI scans. This intermediary layer enables the deep learning models to efficiently handle spatial relationships without direct memory constraints, improving the reliability of tumor progression differentiation while maintaining automation.
3Measurement precision
If precise tumor delineation is performed on volumetric images at multiple follow-up sessions, then accurate radiotherapy outcome evaluation is achieved, but the manual process becomes excessively time-consuming
Solution Approach 1:
The patent replaces the manual mechanical process of delineating tumors on multiple volumetric MRI scans with an automated deep learning framework. The system processes serial MRI images, automatically calculates tumor dimensions at each follow-up session, and evaluates radiotherapy outcomes without manual intervention. This substitution maintains high measurement precision while dramatically improving clinical workflow efficiency.
Solution Approach 2:
The automated framework enables continuous processing of tumor delineation across multiple follow-up sessions without interruption or manual reset. The system maintains consistent measurement standards and continuously evaluates tumor size changes throughout the treatment course, improving productivity by eliminating the repetitive manual workflow while preserving measurement accuracy.
Data Source
AI summary
A system for automatic assessment of therapy outcome in cancer patients treated with radiation therapy, the system comprising a machine-learning-based segmentation model for delineating tumours longitudinally in serial magnetic resonance imaging (MRI) with high precision. Longitudinal segmentations of tumour before and/or during treatment and/or at multiple follow-up sessions after the radiation therapy permits monitoring changes in tumour size and is used in the system for automatic assessment of therapy outcome based on standard clinical criteria.